High-dose angiotensin-converting enzyme inhibition restores body fluid homeostasis in heart-transplant recipients

Journal of the American College of Cardiology

Volumn 41, Issue 3, 2003, Pages 426-432

  Braith, Randy W ^a,c   Mills, Roger M ^a   Wilcox, Christopher S ^b   Davis, Gary L ^a   Hill, James A ^a   Wood, Charles E ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ANGIOTENSIN; ARGIPRESSIN; ATRIAL NATRIURETIC FACTOR; CAPTOPRIL; DIPEPTIDYL CARBOXYPEPTIDASE; SODIUM CHLORIDE;

ADULT; ARTICLE; BLOOD PRESSURE; BODY FLUID; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FLUID RETENTION; HEART TRANSPLANTATION; HOMEOSTASIS; HUMAN; HYPERTENSION; MALE; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SODIUM RETENTION;

EID: 0037419815     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(02)02822-X     Document Type: Article

References (20)

1. th Bethesda Conference. Cardiac Transplantation. J Am Coll Cardiol 1993;22:1-64.
2. Young JB. Cardiac transplantation: patient selection and post-heart transplantation management. In: Mills RM, Young JB, editors. Practical Approaches to the Treatment of Heart Failure. Baltimore, MD: Williams & Wilkins, 1998:226-58.
3. Schofield RS, Schuler BT, Edwards DG, et al. Amplitude and timing of central aortic pressure wave reflections in heart transplant recipients. Am J Hypertens 2002;15:809-15.
4. Scherrer U, Vissing S, Morgan B, et al. Cyclosporine-induced sympathetic activation and hypertension after heart transplantation. N Engl J Med 1990;323:693-9.
5. Myers BD, Sibley R, Newton L. The long-term course of cyclosporine-associated chronic nephropathy. Kidney Int 1988;33:590-600.
6. Ozdogan E, Banner N, Fitzgerald M, Musumeci F, Khaghani A, Yacoub M. Factors influencing the development of hypertension after heart transplantation. J Heart Transplant 1990;9:548-53.
7. Bellet M, Cabrol C, Sassano P, Leger P, Corvol P, Menard J. Systemic hypertension after cardiac transplantation: effect of cyclosporine on the renin-angiotensin-aldosterone system. Am J Cardiol 1985;56:927-31.
8. Braith RW, Mills RM, Wilcox CS, et al. Fluid homeostasis after heart transplantation: the role of cardiac denervation. J Heart Lung Transplant 1996;15:872-80.
9. Braith RW, Plunkett MB, Mills RM. Cardiac output responses during exercise in volume-expanded heart transplant recipients. Am J Cardiol 1998;81:1152-6.
10. Braith RW, Mills RM, Wilcox CS, Mitchell MJ, Hill JA, Wood CE. High dose angiotensin-converting enzyme inhibition prevents fluid volume expansion in heart transplant recipients. J Am Coll Cardiol 2000;36:487-92.
11. Guyton AC. Blood pressure control - Special role of the kidneys and body fluids. Science 1991;252:1813-19.
12. Braith RW, Wood CE, Limacher MC, et al. Abnormal neuroendocrine responses during exercise in heart transplant recipients. Circulation 1992;86:1453-63.
13. Braith RW, Mills RM, Wilcox CS, Davis GL, Wood CE. Breakdown of blood pressure and body fluid homeostasis in heart transplant recipients. J Am Coll Cardiol 1996;27:375-83.
14. Raff H, Wood CE, Kane CW. Arginine vasopressin responses to hypoxia and hypercapnia in late-gestational fetal sheep. Am J Physiol 1991;260:R1077-81.
15. Nichols WW, Nicolini FA. Appendix: useful cardiovascular equations, physical quantities, and nomograms. In: Pepine CJ, Hill JA, Lambert CR, editors. Diagnostic and Therapeutic Cardiac Catheterization, 3rd ed. Baltimore, MD: Williams & Wilkins, 1998:1036.
16. Young JB, Winters WE, Bourge R, Uretsky BF. Function of the heart transplant recipients. J Am Coll Cardiol 1993;22:31-41.
17. Van Brummelen P, Woerle M, Schalekamp MADH. Long term versus short term effects of hydrochlorothiazide on renal hemodynamics and essential hypertension. Clin Sci 1979;56:463-9.
18. Loon NR, Wilcox CS, Unwin RJ. Mechanism of impaired natriuretic response to furosemide during prolonged therapy. Kidney Int 1989; 36:682-9.
19. Petrie MC, Padmanabhan N, McDonald JE, et al. Angiotensin converting enzyme (ACE) and non-ACE dependent angiotensin II generation in resistance arteries from patients with heart failure and coronary heart disease. J Am Coll Cardiol 2001;37:1056-61.
20. Ulrich PJ, Vittorio T, Katz SD, et al. Elevated plasma aldosterone levels despite complete inhibition of the vascular angiotensin-converting enzyme in chronic heart failure. Circulation 2002;106:1055-57.